Fmoc-NH-PEG-NHS is widely used in bioconjugation and pharmaceutical research due to its ability to link biomolecules with high efficiency and specificity. The NHS ester group reacts readily with primary amines, forming stable amide bonds, making it ideal for modifying proteins, peptides, and amine-functionalized surfaces. The PEG spacer improves solubility, reduces aggregation, and enhances the biocompatibility of conjugated molecules. This reagent is particularly valuable in the development of peptide-drug conjugates, PEGylation of proteins, and surface functionalization of nanoparticles and biosensors. The Fmoc group provides a built-in protecting group that can be selectively removed under mild basic conditions, allowing for sequential synthesis in solid-phase or stepwise conjugation strategies. Its dual functionality enables controlled, site-specific modifications in complex biological systems.